Dose: 2.86 to 11.43 ug/kg
Single Dose: 7.1 (7.145)
Frequency: 4 hourly
Route: Inhalation
Instructions: -

Dose: 2.86 to 11.43 ug/kg
Single Dose: 7.1 (7.145)
Frequency: 4 hourly
Route: Inhalation
Instructions: -

. It is of Synthetic origin and belongs to Catecholamine. It belongs to Beta-2 adrenergic agonist pharmacological group on the basis of mechanism of action and also classified in Bronchodilator pharmacological group.The Molecular Weight of Rimiterol (HBr) is 304.20. Its pKa is 8.7, 10.3.

Rimiterol (HBr) is contraindicated in conditions like Hypertension,Thyrotoxicosis,Heart disease.

The severe or irreversible adverse effects of Rimiterol (HBr), which give rise to further complications include Hypokalemia.Rimiterol (HBr) produces potentially life-threatening effects which include Idiosyncratic hypersensitivity reactions. which are responsible for the discontinuation of Rimiterol (HBr) therapy.The signs and symptoms that are produced after the acute overdosage of Rimiterol (HBr) include Tachycardia, Hyperglycemia, Tremor, Hyperinsulinemia, Anxiety, Fall in B.P., Hyperkalemia.The symptomatic adverse reactions produced by Rimiterol (HBr) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Anxiety, Tachycardia, Tremors.

Rimiterol (HBr) is primarily indicated in conditions like Asthma, Bronchitis, Diagnostic bronchodilator test, Obstructive airway disease.

No data regarding the interactions of Rimiterol (HBr) was found.

Drug should not be given to Paediatrics, Pregnant Mothers, Cardiac / Hypertensive Patients, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Aerosols Protect from Sunlight, Moisture and Heat.

Rimiterol should be used with caution in patients with hyperthyroidism, myocardial insufficiency, arrhythmias, hypertension and diabetes mellitus. It should be used with caution during pregnancy.